Moderna, Inc. Quarterly Costs and Expenses in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Moderna, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2020 to Q3 2024.
  • Moderna, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $1.93B, a 49.7% decline year-over-year.
  • Moderna, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $7.77B, a 34% decline year-over-year.
  • Moderna, Inc. annual Costs and Expenses for 2023 was $11.1B, a 12.6% increase from 2022.
  • Moderna, Inc. annual Costs and Expenses for 2022 was $9.84B, a 90.2% increase from 2021.
  • Moderna, Inc. annual Costs and Expenses for 2021 was $5.18B, a 230% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $7.77B $1.93B -$1.91B -49.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $9.69B $1.6B -$607M -27.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $10.3B $1.43B -$795M -35.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $11.1B $2.81B -$699M -19.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $11.8B $3.84B +$1.65B +74.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $10.1B $2.21B -$91M -3.95% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $10.2B $2.23B +$389M +21.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $9.84B $3.5B +$1.7B +94.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $8.14B $2.2B +$787M +55.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $7.35B $2.3B +$1.01B +78.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $6.34B $1.84B +$1.17B +174% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $5.18B $1.8B +$955M +113% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 $4.22B $1.41B +$1.02B +260% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $3.2B $1.29B +$1.1B +584% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $2.1B $671M +$532M +383% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $1.57B $846M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 $392M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $189M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $139M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.